SPECT/CT imaging of 177Lu-labeled phosphoramidate-based PSMA inhibitor with an albumin-binding motif

被引：0
|
作者：
Ling, Xiaoxi [1 ]
Choy, Cindy [2 ]
Latoche, Joseph [1 ]
Geruntho, Jonathan [1 ]
Wu, Yijen [3 ,4 ]
Salamacha, Nathan [3 ,4 ]
Langton-Webster, Beatrice [2 ]
Anderson, Carolyn [1 ,5 ]
Berkman, Clifford [2 ]
机构：
[1] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[2] Canc Targeted Technol, Woodinville, WA USA
[3] UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr Anim Imaging Core, Pittsburgh, PA USA
[4] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA
[5] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 255卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
69
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Preclinical radiation dose optimization, dosimetry and maximum tolerated dose studies of Lu-177-labeled CTT1403, a phosphoramidate-based PSMA inhibitor for targeted radionuclide therapy of prostate cancer.
    Ling, Xiaoxi
    Latoche, Joseph
    Choy, Cindy
    Geruntho, Jonathan
    Laymon, Charles
    Kurland, Brenda
    Langton-Webster, Beatrice
    Berkman, Clifford
    Anderson, Carolyn
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [22] In vivo evaluation of Cerenkov luminescence and SPECT imaging for nanoscale 177Lu-labeled metal-organic framework
    Ding, Wenbing
    Lyu, Jie
    Yu, Yuying
    Tan, Fuyuan
    Yang, Ai
    Lan, Tu
    Liao, Jiali
    Yang, Yuanyou
    Liu, Ning
    Li, Feize
    RADIOCHIMICA ACTA, 2025, 113 (01) : 39 - 49
  • [23] 68Ga/177Lu-Labeled Bivalent Agents for Targeting Hypoxia and PSMA-Binding in Prostate Cancer
    Luo, Yang
    Jin, Wenbin
    Wang, Ran
    Zhao, Ruiyue
    Zhu, Lin
    Kung, Hank F.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (15) : 13491 - 13506
  • [24] Characterization of a 177Lu-labeled albumin binding CXCR4-targeting peptide in a neuroendocrine prostate cancer model
    Astiazaran, Itzel
    Kuo, Hsiou-Ting
    Kurkowska, Sara
    Merkens, Helen
    Colpo, Nadine
    Ng, Pauline
    Ong, Christopher
    Wang, Yuzhuo
    Lin, Kuo-Shyan
    Benard, Francois
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [25] Clinical Implementation of Lu-177 PSMA therapy, including SPECT/CT imaging post therapy
    Toderas, Larisa
    Chen, Delphine
    Iravani, Amir
    Scherzer, Zackary
    Erickson, Mark
    Miyaoka, Robert
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [26] Simultaneous Visualization of 161Tb- and 177Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging
    Borgna, Francesca
    Barritt, Patrick
    Grundler, Pascal, V
    Talip, Zeynep
    Cohrs, Susan
    Zeevaart, Jan Rijn
    Koster, Ulli
    Schibli, Roger
    van der Meulen, Nicholas P.
    Muller, Cristina
    PHARMACEUTICS, 2021, 13 (04)
  • [27] Development and Evaluation of Novel 68Ga/177Lu-Labeled PSMA Inhibitors with Enhanced Pharmacokinetics and Tumor Imaging for Prostate Cancer
    Li, Haiyang
    Liu, Yang
    Yuan, Hongmei
    Cai, Ping
    Wu, Tongtong
    Yang, Zhicong
    Nie, Jiaqi
    Zhang, Wei
    Huang, Zhanwen
    Liu, Nan
    Chen, Yue
    Zhou, Zhijun
    MOLECULAR PHARMACEUTICS, 2025, 22 (03) : 1584 - 1597
  • [28] Investigation of 68Ga/177Lu-labeled FAP-based inhibitor for diagnostic and therapeutic applications
    Imlimthan, Surachet
    Menendez, Elena
    Escudero-Castellanos, Alondra
    Moon, Euy Sung
    Laeppchen, Tilman
    Rathke, Hendrik
    Afshar-Oromieh, Ali
    Roesch, Frank
    Rominger, Axel
    Gourni, Eleni
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S56 - S57
  • [29] A 177Lu-labeled albumin-binder-conjugated PSMA-617 derivative with greatly enhanced radiation dose delivered to LNCaP tumor xenografts
    Kuo, Hsiou-Ting
    Merkens, Helen
    Zhang, Zhengxing
    Uribe, Carlos
    Zhang, Chengcheng
    Lau, Joseph
    Colpo, Nadine
    Benard, Francois
    Lin, Kuo-Shyan
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [30] Clinical translation of the albumin-binding radioligand 177Lu-(S)-Ibu-DAB-PSMA in patients with mCRPC: Enhancing clinical efficacy of PSMA-targeted RLT
    Fernandez, R.
    Nicolai, H.
    Ritt, P.
    Soza-Ried, C.
    Rogers, A.
    Qin, Y.
    Meckel, M.
    Fliegert, F.
    Ceballos, M.
    Wettlin, J.
    Amaral, H.
    Zhernosekov, K.
    Borgna, F.
    Deberle, L. M.
    Schibli, R.
    Mueller, C.
    Martinez, C.
    Del Castillo, C.
    Kramer, V
    EUROPEAN UROLOGY, 2024, 85 : S1441 - S1441
12345